Advances in Chronic Pain: New Solutions to Break Through Resistant Pain

Chronic pain affects 1 in 5 Australians, often persisting due to changes in neural and immune responses. This webinar explores the endocannabinoid system’s role in pain regulation and highlights palmitoylethanolamide (PEA) as a safe, effective therapy to reduce inflammation and help patients break free from persistent pain.

This content is for healthcare practitioners only. Please log in to access it or apply for an account.

Related Posts

Live webinars, on-demand courses, and thought-leader panels—all at your fingertips.